Ambiq Micro, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Ambiq Micro reports a substantial 89.7% increase in net sales for the quarter ended June 30, 2026, driven by new product launches and customer adoption, while continuing to invest heavily in R&D.
NYSE
Ambiq Micro's Q1 2026 results show a 59.3% surge in net sales driven by new product launches and increased customer demand, though net loss widened.
NYSE
Ambiq Micro reports improved gross margins and reduced net loss for the nine months ended September 30, 2025, driven by a strategic shift away from Mainland China following its July 2025 IPO.
NYSE
Ambiq Micro reports improved gross margins and reduced net losses in Q2 2025, driven by a strategic pivot away from Mainland China and a successful post-period IPO.